Table 1

Clinical characteristics of monozygotic twin pairs.

Twin pair no

Gender

Age

Duration of MS (years)

Type of MS

EDSS

Immunomodulatory treatment


1

F

54

11

SP

1.5

n.t.

F

54

Healthy/0

Healthy

2

F

48

1

RR

4.0

IFN-β-1a

F

48

Healthy/0

Healthy

3

F

55

9

SP

7.0

IFN-β-1b

F

55

Healthy/0

Healthy

4

M

53

23

SP

6.5

n.t.

M

53

Healthy/0

Healthy

5

F

33

5

RR

4.0

IFN-β-1a

F

33

Healthy/0

Healthy

6

F

54

3

RR

4.5

IFN-β-1b

F

54

Healthy/0

Healthy

7

M

66

11

SP

6.5

n.t.

M

66

Healthy/0

Healthy

8

M

46

22

SP

6.5

n.t.

M

46

Healthy/0

Healthy


F female; M male; n.t. no treatment; EDSS Expanded Disability Status Scale; IFN-β beta-interferon

Särkijärvi et al. BMC Medical Genetics 2006 7:11   doi:10.1186/1471-2350-7-11

Open Data